by Madaline Spencer | Jan 10, 2025
Gregory Grabowski, MD, discusses the use of whole genome sequencing and artificial intelligence (AI) in epigenetics and epigenomics. Epigenetics and epigenomics provide critical insights into why family members with the same disease may exhibit distinct...
by Madaline Spencer | Jan 9, 2025
David Smerkous, AI PhD Student, Oregon State University, discusses artificial intelligence (AI) in healthcare. Mr. Smerkous describes concerns relating to AI, including its impact on the jobs of laboratory technicians. While this technology can help with...
by Madaline Spencer | Jan 8, 2025
David Warnock, MD, Professor of Medicine (Emeritus), University of Alabama at Birmingham, discusses recent advances in Fabry disease clinical research. Fabry disease is a rare genetic, multisystemic lysosomal disease characterized by specific cutaneous,...
by Madaline Spencer | Jan 7, 2025
Ozlem Goker-Alpan, MD, Founder and Chief Medical Officer of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC), discusses her work in lysosomal storage diseases and the GRIDS conference. Lysosomal diseases are a group of rare...
by Madaline Spencer | Jan 6, 2025
Joseph E. Sullivan, MD, Professor of Neurology & Pediatrics at University of California San Francisco and Director of Benioff Children’s Hospital Pediatric Epilepsy Center of Excellence, discusses zovrevunersen for the treatment of patients with Dravet syndrome....
